Wednesday, May 31, 2017

EOD Review On 31-May-2017 : Calls for Next Trading Day

www.AamAadmiSoftware.com (EOD Review on 31 May 2017)

My System Calls:

1) Levels to watch are 9643.3 and 9608.8

2) Sell Below 9556.5 SL 9587.5 TGT
3) Buy Above 9618.5 SL 9587.5 TGT 9643.3, 9659.48, 9677.26

4) Supports/Resistances to Watch For :-

9573.76
9590.48
9608.26
9624.98
9642.76
9659.48
9677.26

Camarilla Calls:
1) Sell Below 9607.07 SL 9616.56 TGT 9594.09, 9585.81
2) Sell Below 9635.54 SL 9645.02 TGT 9629.21, 9622.89, 9616.56
3) Buy Above 9616.56 SL 9607.07 TGT 9622.89, 9629.21, 9635.54
4) Buy Above 9645.02 SL 9635.54 TGT 9663.09


BANKNIFTY : Levels to watch are 23402.9 and 23240.6

USDINR-1 : Levels to watch are 64.78 and 64.68

RELIANCE : Levels to watch are 1356.95 and 1335.35

SBIN : Levels to watch are 291.8 and 287.6


Nifty Options Data:
Highest OI : NIFTY9400PE NIFTY9700CE
Highest Rise in OI : NIFTY9400PE NIFTY9600CE
Highest Fall in OI : NIFTY3500PE NIFTY3500CE
Highest Volume : NIFTY9500PE NIFTY9700CE


FII/DII Figures:
FII Cash Net = N.A.
FII F&O Net = 303.48
FII F&O OI = 157433.5
DII Cash Net = N.A.


Long Build Up: IOC, ICICIBANK, M&M, ESCORTS, GAIL
Short Covering: MFSL, RCOM, JETAIRWAYS, MCDOWELL-N, PVR

Short Build Up: BANKINDIA, CANBK, BALKRISIND, INFRATEL, HDFC
Long Unwinding: NIITTECH, PFC, GODREJIND, AUROPHARMA, INDIACEM


Volume Shockers (Futures) :
MCDOWELL-N

Swing Trading (Futures):
1. AUROPHARMA Buy Above 579.69
2. HDIL Buy Above 90.39

5 Best Performing Stocks since Expiry:
M&MFIN, HEG, REIAGROLTD, MCDOWELL-N, TATACOMM

5 Worst Performing Stocks since Expiry:
RCOM, VIDEOIND, KOHINOOR, DHAMPURSUG, SUNPHARMA

Position as per Trade with Trend :

NIFTY Hold Long taken at 9465.32 On 25-05-2017 StopLoss 9577.72 | Profit so far 160.73

BANKNIFTY Hold Long taken at 22773.2 On 25-05-2017 StopLoss 23110.85 | Profit so far 548.55

RELIANCE Hold Long taken at 1318.38 On 26-05-2017 StopLoss 1342.52 | Profit so far 27.77

SBIN Hold Short taken at 303.12 On 22-05-2017 StopLoss 291.53 | Profit so far 13.42

No comments:

Post a Comment